Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00185809
Status:
COMPLETED
Last Update Posted:
2010-07-20
First Post:
2005-09-12
Brief Title:
Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy Part I Radioiodide Imaging Study
Sponsor:
Stanford University
Organization:
Stanford University
Study Overview
Official Title:
Scintigraphic Assessment of I- Transport in Metastatic Breast Cancer and Evaluation of I31I Ablative Therapy Part I Radioiodide Imaging Study
Status:
COMPLETED
Status Verified Date:
2010-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to examine breast cancers that express the protein NIS that may be found in malignant breast tissues and to evaluate proteins found in blood and their relationship to NIS to test whether iodide can be concentrated by breast cells to possibly treat some breast cancers with radioactive iodine and to calculate the amount of radioactive iodine entering breast cancer cells how long your cancer retains the agent as well as how much is taken up by other organs particularly the thyroid gland
Detailed Description:
To demonstrate iodide uptake capacity of breast cancer metastases by imaging women with iodide radioisotope 123I and calculating potential ablative dose of radioactive iodide 131I
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| NIH | None | None | None |
| 75632 | None | None | None |
| BRSMTS0002 | None | None | None |
| NCT00185809 | None | None | None |